- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04948359
Determining Optimal Cuff Volume in Pediatric Patients
Determining Optimal Cuff Volume for Cuffed Endotracheal Tubes Commonly Used in Pediatric Patients: a Prospective Observational Study
Study Overview
Status
Detailed Description
Design:
This is a prospective, single blinded, observational study. In case of 2 independent variables in the multiple linear regression analysis, the required sample size was calculated as at least 40 in order to determine the large effect width (f2=0.35) at 0.80 power and 0.05 error levels. Since the study will be carried out with 3 different tube diameters, the sample size has been determined as 120 in total (G*Power software 3.1.9). In the Bland and Altman method, it was stated that when there are at least 100 observations, the 95% confidence level can be determined in the range of ±0.34s (where "s" is the standard deviation of the differences between the two measurements). For this reason, it is seen that the determined sample number of 120 is also sufficient for the Bland&Altman method. Power analysis was made with G*Power 3.1.9.7 statistical package program; group=3, n=127 (n1=42, n2=43, n3=42), α=0.05, Effect Size (f)=0.34; power = 93%.
Methods: Pediatric patients younger than 18 yr old who will be operated in our hospital and intubated with cuffed tubes numbered 4.5, 5.0, and 5.5 under general anesthesia will be included in this prospective observational study. After standard monitoring in the supine position, anesthesia will be induced with a mixture of O2 / air (50/50%) and 8% Sevoflurane, and then vascular access will be established. Intravenous (IV) 2-3 mg/kg propofol and 1 μgr/kg fentanyl will be administered to patients with IV access. For muscle relaxation after loss of consciousness, 0.5 mg/kg rocuronium will be given IV. After the patients are paralyzed, a 3 cm roll pad will be placed under their shoulders and airway ultrasonography imaging will be performed with the head slightly extended and in the supine-neutral position. The linear probe will be placed transversely in the anterior neck of the patients and moved in a cefo-caudal direction to view the cricoid cartilage. The cricoid cartilage appears as a hypoechoic round structure with hyperechoic margins. At this level, the transverse diameter of the subglottic air column will be measured in millimeters (mm) on the USG image. The formulas in the literature and the subglottic transverse trachea diameter measured by ultrasound will be used to select the most appropriate endotracheal tube for the pediatric patients. After the appropriate cuffed tube is attached to the patient, the cuff will be inflated with air through a 5 milliliter (ml) injector, and cuff pressure will be measured with a cuff manometer. The optimal cuff volume will be determined by giving or withdrawing the 0.2 ml volume to ensure optimum cuff pressure (20-25 cmH2O) and this value will be recorded. Demographic data of the patients, subglottic transverse airway diameter measured by ultrasonography, endotracheal tube number placed in the patient, given cuff volume, measured cuff pressure value, tube change requirement, peak airway pressure, operation time and postoperative airway complications (sore throat, desaturation, stridor, hoarseness, cough) will be recorded.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Çankaya
-
Ankara, Çankaya, Turkey, 06800
- Ankara City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Pediatric patients younger than 18 yr old who will be operated in our hospital and intubated with cuffed tubes numbered 4.5, 5.0, and 5.5 under general anesthesia are included in this study.
Exclusion Criteria:
- ASA physical status score of III and IV,
- Tracheostomy, airway obstruction or other airway anatomical abnormalities,
- Difficult intubation prediction,
- History of airway hyperreactivity or bronchial asthma,
- Body mass index above the 85th percentile and below the 5th percentile,
- Patients whose parents were unable to read, understand and sign the consent form or whose parents did not want to sign the consent form will not included in the study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group I (The patients intubated with cuffed ETT of ID number 4.5)
Groups are classified according to endotracheal tube ID numbers.
In this group we aimed to determine the optimal cuff volume that ensures airway safety in pediatric patients intubated with a 4.5 size internal diameter (ID) endotracheal cuff tube.
|
Groups are classified according to endotracheal tube ID numbers.
Inflating the endotracheal tube cuff with more than normal volume leads to decreased capillary blood flow and mucosal damage, while inflating the endotracheal tube cuff with less than normal volume leads to insufficient ventilation of the patient and an increase in the risk of pulmonary aspiration.
The cuff pressure safety range is recommended between 20-30 cmH2O to prevent gas leakage and the risk of aspiration.
We aimed to determine the optimal cuff volume that ensures airway safety in pediatric patients intubated with a 4.5 size inner diameter (ID) endotracheal cuff tube.
Choosing the appropriate tube for endotracheal intubation is of great importance, especially in children.
In our study, the transverse diameter of the subglottic airway will be measured by USG for the selection of the appropriate ETT to be used for each patient (the formulas for the selection of ETT in the literature will be used)
|
Group II (The patients intubated with cuffed ETT of ID number 5.0)
Groups are classified according to endotracheal tube ID numbers.
In this group we aimed to determine the optimal cuff volume that ensures airway safety in pediatric patients intubated with a 5.0 size internal diameter (ID) endotracheal cuff tube.
|
Groups are classified according to endotracheal tube ID numbers.
Inflating the endotracheal tube cuff with more than normal volume leads to decreased capillary blood flow and mucosal damage, while inflating the endotracheal tube cuff with less than normal volume leads to insufficient ventilation of the patient and an increase in the risk of pulmonary aspiration.
The cuff pressure safety range is recommended between 20-30 cmH2O to prevent gas leakage and the risk of aspiration.
We aimed to determine the optimal cuff volume that ensures airway safety in pediatric patients intubated with a 5.0 size inner diameter (ID) endotracheal cuff tube.
Choosing the appropriate tube for endotracheal intubation is of great importance, especially in children.
In our study, the transverse diameter of the subglottic airway will be measured by USG for the selection of the appropriate ETT to be used for each patient (the formulas for the selection of ETT in the literature will be used)
|
Group III (The patients intubated with cuffed ETT of ID number 5.5)
Groups are classified according to endotracheal tube ID numbers.
In this group we aimed to determine the optimal cuff volume that ensures airway safety in pediatric patients intubated with a 5.5 size internal diameter (ID) endotracheal cuff tube.
|
Groups are classified according to endotracheal tube ID numbers.
Inflating the endotracheal tube cuff with more than normal volume leads to decreased capillary blood flow and mucosal damage, while inflating the endotracheal tube cuff with less than normal volume leads to insufficient ventilation of the patient and an increase in the risk of pulmonary aspiration.
The cuff pressure safety range is recommended between 20-30 cmH2O to prevent gas leakage and the risk of aspiration.
We aimed to determine the optimal cuff volume that ensures airway safety in pediatric patients intubated with a 5.5 size inner diameter (ID) endotracheal cuff tube.
Choosing the appropriate tube for endotracheal intubation is of great importance, especially in children.
In our study, the transverse diameter of the subglottic airway will be measured by USG for the selection of the appropriate ETT to be used for each patient (the formulas for the selection of ETT in the literature will be used)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Optimal intracuff volume
Time Frame: during surgery
|
To obtain the minimum and optimal cuff volume that will provide adequate ventilation and protect from pulmonary aspiration in pediatric patients who is intubated with cuffed endotracheal tubes inner diameter of 4.5, 5.0, 5.5 mm.
|
during surgery
|
Formula for optimal cuff volume.
Time Frame: 15 minute
|
We would like to create a formula to calculate the estimated cuff volume that should be inflated within the safe cuff pressure range for each patient intubated with an ETT ID number 4.5, 5.0, and 5.5.
|
15 minute
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Formula for subglottic transverse tracheal diameter
Time Frame: 15 minute
|
We would like to develop a formula to predict subglottic transverse tracheal diameter with a regression model to be established by usin subglottic tracheal diameter data measured by USG in each patient.
|
15 minute
|
Postoperative complications
Time Frame: 1 hour
|
The other secondary objective of this study is to examine correlation between cuff volume and postoperative complications
|
1 hour
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Feyza Sever, Ankara City Hospital Bilkent
- Principal Investigator: Kahir Güneş, Ankara City Hospital Bilkent
- Study Director: Sengül Özmert, Ankara City Hospital Bilkent
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- E2-21-76
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Children, Only
-
Hospital Authority, Hong KongCompleted
-
Semmelweis UniversityRecruitingAnesthesia | Children, OnlyHungary
-
University of SaskatchewanCompleted
-
T.C. ORDU ÜNİVERSİTESİUnknownAdolescent | Children, Only
-
St. Justine's HospitalCompletedChildren, Only | Anesthesia; ReactionCanada
-
McMaster UniversityHamilton-Wentworth Catholic District School Board; Start2FinishCompletedPhysical Activity | Children, OnlyCanada
-
Utah State UniversityUtah Agriculture Experiment StationCompletedChildren, Only | Raman SpectroscopyUnited States
-
Children's Hospital of PhiladelphiaFood and Drug Administration (FDA)Recruiting
-
University of VirginiaCompleted
-
Victor Contreras, MSNPontificia Universidad Catolica de ChileTerminatedAnesthesia | Children, Only | ElectroencephalographyChile
Clinical Trials on Group I (The patients intubated with cuffed ETT of ID number 4.5)
-
Assiut UniversityRecruiting
-
Assiut UniversityNot yet recruitingLocally Advanced Cervical Carcinoma
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States